---
figid: PMC8867969__MBT2-15-613-g005
figtitle: Convergent phenotypic evolution towards fosfomycin collateral sensitivity
  of Pseudomonas aeruginosa antibiotic‐resistant mutants
organisms:
- Pseudomonas aeruginosa
- Homo sapiens
organisms_ner:
- Escherichia coli str. K-12 substr. MG1655
pmcid: PMC8867969
filename: MBT2-15-613-g005.jpg
figlink: /pmc/articles/PMC8867969/figure/mbt213817-fig-0001/
number: F1
caption: Schematic representation of the Pseudomonas aeruginosa fosfomycin resistome.
  Fosfomycin (FOF) enters the cell through GlpT transporter (Winkler, ) and, once
  inside the cell, fosfomycin could be inactivated by FosA. A reduced expression of
  fosA increases the intracellular amount of active fosfomycin. Active fosfomycin
  blocks the de novo peptidoglycan synthesis by the inhibition of MurA (Kahan et al.,
  ). In this situation, the synthesis of the peptidoglycan may be maintained by the
  peptidoglycan‐recycling pathway, whose loss‐of‐function leads to hyper‐susceptibility
  to fosfomycin (Borisova et al., ). Data shown in this work propose that a reduced
  expression of both, genes belonging to the peptidoglycan‐recycling pathway and fosA,
  is at the molecular basis of collateral sensitivity to fosfomycin observed in different
  antibiotic‐resistant mutants.
papertitle: Convergent phenotypic evolution towards fosfomycin collateral sensitivity
  of Pseudomonas aeruginosa antibiotic‐resistant mutants.
reftext: Pablo Laborda, et al. Microb Biotechnol. 2022 Feb;15(2):613-629.
year: '2022'
doi: 10.1111/1751-7915.13817
journal_title: Microbial Biotechnology
journal_nlm_ta: Microb Biotechnol
publisher_name: John Wiley and Sons Inc.
keywords: ''
automl_pathway: 0.9454729
figid_alias: PMC8867969__F1
figtype: Figure
redirect_from: /figures/PMC8867969__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8867969__MBT2-15-613-g005.html
  '@type': Dataset
  description: Schematic representation of the Pseudomonas aeruginosa fosfomycin resistome.
    Fosfomycin (FOF) enters the cell through GlpT transporter (Winkler, ) and, once
    inside the cell, fosfomycin could be inactivated by FosA. A reduced expression
    of fosA increases the intracellular amount of active fosfomycin. Active fosfomycin
    blocks the de novo peptidoglycan synthesis by the inhibition of MurA (Kahan et al.,
    ). In this situation, the synthesis of the peptidoglycan may be maintained by
    the peptidoglycan‐recycling pathway, whose loss‐of‐function leads to hyper‐susceptibility
    to fosfomycin (Borisova et al., ). Data shown in this work propose that a reduced
    expression of both, genes belonging to the peptidoglycan‐recycling pathway and
    fosA, is at the molecular basis of collateral sensitivity to fosfomycin observed
    in different antibiotic‐resistant mutants.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - murB
  - murA
  - anmK
  - glpT
---
